我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
9
3 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1870
进行中(未招募)
1
11.1%
已完成
3
33.3%
尚未招募
2
22.2%
招募中
Unknown
暂无批准数据
- Clinical Research Malaysia (CRM) signed a strategic MoU with CSI Medical Research to promote Malaysia's clinical research capabilities to international biotech firms and advance training initiatives for study coordinators. - Malaysia achieved a record five First-in-Human studies in 2024, the highest number since CRM's Phase 1 Realisation Project launched in 2016, demonstrating growing early-phase research capabilities. - The country initiated 267 new sponsored clinical research studies in 2024, bringing the total to over 2,500 studies since CRM's establishment in 2012. - Sunway Medical Centre partnered with the National Institutes of Health to develop a dedicated Phase 1 Clinical Trial Unit, expected to be completed and accredited by 2026.